Bharat Immunologicals (India) Financial Indicators Patterns

BIBCL -- India Stock  

INR 8.70  0.30  3.33%

Please use Bharat Immunologicals fundamental data analysis to find out if markets are presently mispricing the company. We found twenty-three available fundamental indicators for Bharat Immunologicals Biologicals Corp Ltd which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Bharat Immunologicals fundamentals including its Operating Margin, Revenue, Debt to Equity, as well as the relationship between Price to Earning and Net Income . Use Bharat Immunologicals to protect your portfolios against small markets fluctuations. The stock experiences unexpected downward movement. The market is reacting to new fundamentals. Check odds of Bharat Immunologicals to be traded at 8.35 in 30 days.

Bharat Immunologicals Company Summary

Bharat Immunologicals competes with Biocon, Biocon, Syngene International, Sequent Scientific, and Panacea Biotec. Bharat Immunologicals Biologicals Corporation Limited, a biotechnology company, manufactures and markets a range of pharmaceuticals products in India. The company was founded in 1989 and is based in Bulandshahr, India. Bharat Immunologicals operates under Biotechnology classification in India and is traded on Bombay Stock Exchange.

Bharat Immunologicals Beta vs Gross Profit

Bharat Immunologicals Biologicals Corp Ltd is rated below average in beta category among related companies. It is rated below average in gross profit category among related companies fabricating about  175,651,163  of Gross Profit per Beta.

Bharat Immunologicals Systematic Risk

Time Period
  Portfolio Suggestion    
Execute Function
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of thirty-eight. The Beta measures systematic risk based on how returns on Bharat Immunologicals correlated with the market. If Beta is less than 0 Bharat Immunologicals generally moves in the opposite direction as compared to the market. If Bharat Immunologicals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Bharat Immunologicals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Bharat Immunologicals is generally in the same direction as the market. If Beta > 1 Bharat Immunologicals moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

Distress Rating

Bharat Immunologicals Financial Distress Probability

Chance of Financial Distress
Bharat Immunologicals Biologicals Corp Ltd has more than 51 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Compare Bharat Immunologicals

Compare Bharat Immunologicals To Peers

Bharat Immunologicals Opportunity Range

March 21, 2019 Opportunity Range

Check also Trending Equities. Please also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.